AI can now create genome viruses in laboratories and redesign toxins to evade controls, raising biosafety alert and rise of ...

DNA is the raw material of modern medicine yet is the only part of drug development not accessible at the lab bench. DNA synthesis, the first step in most biological workflows including gene synthesis ...

DNA synthesis is vital to several processes in biopharmaceutical innovation, including the development of gene therapies, CRISPR gene editing, antisense oligonucleotides and RNA therapies. The need ...

Telesis Bio’s Gibson SOLA platform is a revolutionary next-generation technology that provides independence for researchers, giving them full control of DNA and mRNA synthesis and enabling them to ...

There’s an old saying about a dollar waiting on a dime. In other words, a monumental endeavor may become stuck at some point if a key preliminary element remains unavailable. The saying could be ...